Drug-eluting stenting for unprotected left main coronary artery disease: Are we ready to replace bypass surgery? (vol 47, pg 898, 2006)

被引:1
|
作者
Baim, DS
Mauri, L
Cutlip, DC
机构
关键词
D O I
10.1016/j.jacc.2006.01.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1091 / 1091
页数:1
相关论文
共 50 条
  • [31] Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery Reply
    Wu, Chuntao
    Hannan, Edward L.
    Walford, Gary
    Faxon, David P.
    ANNALS OF THORACIC SURGERY, 2009, 87 (05): : 1652 - 1653
  • [32] Five-Year Outcomes after Drug-Eluting Stent versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease
    Park, Duk-Woo
    Lee, Jong-Young
    Kim, Won-Jang
    Kang, Soo-Jin
    Lee, Seung-Whan
    Kim, Young-Hak
    Lee, Cheol Whan
    Kim, Jae-Joong
    Park, Seong-Wook
    Park, Seung-Jung
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 16B - 16B
  • [33] Drug-eluting stents versus coronary artery bypass grafting for left-main coronary artery disease
    Takagi, Hisato
    Ando, Tomo
    Umemoto, Takuya
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 (04) : 697 - 709
  • [34] CLINICAL OUTCOMES AFTER DRUG-ELUTING STENT IMPLANTATION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE
    Pollice, F.
    Pollice, P.
    Jacob, L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S40 - S40
  • [35] Treatment of unprotected left main coronary artery disease with drug-eluting stents: is it time for a randomized trial?
    Chieffo, A
    Colombo, A
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (08): : 396 - 400
  • [36] Percutaneous treatment with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery stenosis
    Ziani, A.
    Ghenim, R.
    Bongard, V.
    Boudou, N.
    Lhermusier, T. H.
    Ouldzein, H.
    Cerene, A.
    Fournial, G.
    Dumonteil, N.
    Carrie, D.
    EUROPEAN HEART JOURNAL, 2008, 29 : 681 - 681
  • [37] Treatment of unprotected left main coronary artery disease with drug-eluting stents: is it time for a randomized trial?
    Alaide Chieffo
    Antonio Colombo
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 396 - 400
  • [38] Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: A Single Center Retrospective Experience
    Simard, Trevor
    Hibbert, Benjamin
    Chong, Aun-Yeong
    Ruchin, Peter
    Le May, Michel
    Labinaz, Marino
    Froeschl, Michael
    So, Derek
    Glover, Christopher
    Marquis, Jean-Francois
    O'Brien, Edward
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 80 (02) : E15 - E22
  • [39] Transradial stenting for unprotected left main coronary artery stenosis: Drug-eluting stent vs bare metal stent
    Cheng, C. I.
    Hsieh, Y. K.
    Fang, C. Y.
    Chen, S. M.
    Yang, C. H.
    Hsueh, S. K.
    Bhasin, A.
    Yip, H. K.
    Hang, C. L.
    Wu, C. J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8B): : 52C - 52C
  • [40] Effect of different generations of drug-eluting stents on the prognosis of patients with stenting unprotected left main coronary artery.
    Shugushev, Z. Kh
    Maximkin, D. A. Daniil
    Chepurnoy, A. G.
    Safonova, O. O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 603 - 603